Rating History for Avalyn Pharma (AVLN) by Morgan Stanley

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/26/2026 Judah Frommer New Coverage Overweight
(N/A)
53.00
(N/A)
28.41
(32.97)
16.05% Details